Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
<p dir="ltr">Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with poor prognosis, early recurrence, and the lack of durable chemotherapy responses and specific targeted treatments. The recent FDA approval for immune checkpoint inhibition in c...
Saved in:
| Main Author: | Adviti Naik (673163) (author) |
|---|---|
| Other Authors: | Julie Decock (44558) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik (673163)
Published: (2019) -
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
by: Remy Thomas (702843)
Published: (2021) -
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
by: Aranka Brockmueller (11064675)
Published: (2021) -
Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice
by: Tomas Venit (17248420)
Published: (2023) -
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
by: Samson Mathews Samuel (11008848)
Published: (2023)